| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
1 T Lymphocytes from B-CLL Patients Recognize ULBP3 Expressed on Leukemic B Cells and Up-Regulated by Trans-Retinoic Acid
1 Laboratory of Immunology, National Cancer Research Institute, Genoa, Italy; 2 Clinical Hematology, Department of Internal Medicine, University of Genoa, Genoa, Italy; 3 Department of Immunology, Eberhard-Karls University, Tuebingen, Germany; 4 Laboratory of Immunology and Oncology, Institute for Cancer Research, Candiolo, Italy; and 5 Laboratory of Tumor Immunology and 6 Department of Oncology, Università Vita Salute and Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Milan, Italy
We analyzed 38 untreated patients with chronic lymphocytic leukemia of B-cell type (B-CLL): 24 low-, 8 intermediate-, and 6 high-risk stage. In 15 patients (13 low risk and 2 intermediate risk), circulating V
1 T lymphocytes were significantly increased (100 to 300 cells/µL) compared with most intermediate, all high-risk stage, and 15 healthy donors (50 to 100 cells/µL). We studied these V1 T lymphocytes and observed that they proliferated in vitro and produced tumor necrosis factor 
or IFN-
in response to autologous leukemic B cells but not to normal lymphocytes. However, they were unable to kill resting autologous B cells, which lack the MHC-related MIC-A antigen and express low levels of the UL16-binding protein (ULBP) 3 and undetectable levels of ULBP1, ULBP2, and ULBP4. All these molecules are reported ligands for the NKG2D receptor, which is expressed by T cells and activates their cytolytic function. The V1 T lymphocytes studied were able to lyse the ULBP3+ C1R B-cell line upon transfection with MIC-A. More importantly, they also lysed autologous B-CLL cells when transcription and expression of MIC-A or up-regulation of ULBP3 were achieved either by activation or by exposure to trans-retinoic acid. The NKG2D receptor expressed on V1 T cells was involved in the recognition of B-CLL. Finally, in six patients with low numbers of circulating V1 T cells and undetectable ULBP3, the disease progressed over 1 year, whereas no progression occurred in patients with high V1 T lymphocytes and detectable/inducible ULBP3. These data suggest that V1 T lymphocytes may play a role in limiting the progression of B-CLL.
This article has been cited by other articles:
|
|
 |
|
  N. L. Bryant, C. Suarez-Cuervo, G. Y. Gillespie, J. M. Markert, L. B. Nabors, S. Meleth, R. D. Lopez, and L. S. Lamb Jr. Characterization and immunotherapeutic potential of {gamma}{delta} T-cells in patients with glioblastoma Neuro-oncol, January 1, 2009; 11(4): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Caligaris-Cappio and P. Ghia Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease? J. Clin. Oncol., September 20, 2008; 26(27): 4497 - 4503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Catellani, A. Poggi, A. Bruzzone, P. Dadati, J. L. Ravetti, M. Gobbi, and M. R. Zocchi Expansion of V{delta}1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins Blood, March 1, 2007; 109(5): 2078 - 2085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kabelitz, D. Wesch, and W. He Perspectives of {gamma}{delta} T Cells in Tumor Immunology Cancer Res., January 1, 2007; 67(1): 5 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lopez-Soto, A. Quinones-Lombrana, R. Lopez-Arbesu, C. Lopez-Larrea, and S. Gonzalez Transcriptional Regulation of ULBP1, a Human Ligand of the NKG2D Receptor J. Biol. Chem., October 13, 2006; 281(41): 30419 - 30430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Sutherland, B. Rabinovich, N. J. Chalupny, P. Brawand, R. Miller, and D. Cosman ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15 Blood, August 15, 2006; 108(4): 1313 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Poggi, C. Prevosto, A.-M. Massaro, S. Negrini, S. Urbani, I. Pierri, R. Saccardi, M. Gobbi, and M. R. Zocchi Interaction between Human NK Cells and Bone Marrow Stromal Cells Induces NK Cell Triggering: Role of NKp30 and NKG2D Receptors J. Immunol., November 15, 2005; 175(10): 6352 - 6360. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
